Randomized clinical trial of the impact of insulin therapy on liver function in patients undergoing major liver resection

British Journal of Surgery

Volumn 100, Issue 5, 2013, Pages 610-618

  Hassanain, M ^a,e   Metrakos, P ^a,e   Fisette, A ^d   Doi, S A R ^f   Schricker, T ^b   Lattermann, R ^b   Carvalho, G ^b   Wykes, L ^c   Molla, H ^c   Cianflone, K ^d  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874609900     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9034     Document Type: Article

References (35)

1. Lyratzopoulos G, Tyrrell C, Smith P, Yelloly J,. Recent trends in liver resection surgery activity and population utilization rates in English regions. HPB (Oxford) 2007; 9: 277-80.
2. Clavien P, Petrowsky H, DeOliveira M, Graf R,. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 2007; 356: 1545-1559.
3. Wanless IR, Lentz JS,. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-1110.
4. Aloia T, Sebagh M, Plasse M, Karam V, Lévi F, Giacchetti S, et al., Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 2006; 24: 4983-4990.
5. Schindl M, Millar A, Redhead D, Fearon K, Ross J, Dejong C, et al., The adaptive response of the reticuloendothelial system to major liver resection in humans. Ann Surg 2006; 243: 507-514.
6. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, et al., Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7: 1034-1044.
7. Ljungqvist O, Thorell A, Gutniak M, Häggmark T, Efendic S,. Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance. J Am Coll Surg 1994; 178: 329-336.
8. Maeda H, Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Hanazaki K,. Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 2010; 199: 8-13.
9. Thorell A, Alston-Smith J, Ljungqvist O,. The effect of preoperative carbohydrate loading on hormonal changes, hepatic glycogen, and glucoregulatory enzymes during abdominal surgery. Nutrition 1996; 12: 690-695.
10. Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, et al.,; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
11. Albacker T, Carvalho G, Schricker T, Lachapelle K,. Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy. Ann Thorac Surg 2007; 84: 1920-1927.
12. Sato H, Lattermann R, Carvalho G, Sato T, Metrakos P, Hassanain M, et al., Perioperative glucose and insulin administration while maintaining normoglycemia (GIN therapy) in patients undergoing major liver resection. Anesth Analg 2010; 110: 1711-1718.
13. Vauthey J, Chaoui A, Do K, Bilimoria M, Fenstermacher M, Charnsangavej C, et al., Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-519.
14. Schindl MJ, Redhead DN, Fearon KCH, Garden OJ, Wigmore SJ, Edinburgh Liver Surgery and Transplantation Experimental Research Group eLISTER. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005; 54: 289-296.
15. Dindo D, Demartines N, Clavien PA,. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
16. Ueda T, Sakabe T, Oka M, Maeda Y, Nishida M, Murakami F, et al., Levels of interleukin (IL)-6, IL-8, and IL-1 receptor antagonist in the hepatic vein following liver surgery. Hepatogastroenterology 2000; 47: 1048-1051.
17. Alkozai EM, Nijsten MW, de Jong KP, de Boer MT, Peeters PM, Slooff MJ, et al., Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg 2010; 251: 300-306.
18. Muraoka I, Soyama A, Takatsuki M, Tomonaga T, Hidaka M, Kanematsu T, et al., Transition of serum alkaline phosphatase isoenzymes during liver regeneration in humans. Hepatogastroenterology 2011; 58: 1436-1438.
19. Albacker T, Carvalho G, Schricker T, Lachapelle K,. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86: 20-27.
20. Fisette A, Hassanain M, Metrakos P, Doi SA, Salman A, Schricker T, et al., High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. J Clin Endocrinol Metab 2012; 97: 217-226.
21. Valverde AM, Fabregat I, Burks DJ, White MF, Benito M,. IRS-2 mediates the antiapoptotic effect of insulin in neonatal hepatocytes. Hepatology 2004; 40: 1285-1294.
22. Tang L, Tian F, Tao W, Cui J,. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury during partial hepatectomy. World J Surg 2007; 31: 2039-2043.
23. Caraceni P, Nardo B, Domenicali M, Turi P, Vici M, Simoncini M, et al., Ischemia-reperfusion injury in rat fatty liver: role of nutritional status. Hepatology 1999; 29: 1139-1146.
24. Astarcioglu I, Adam R, Gigou M, Isaac J, Bismuth H,. High levels of glycogen in the donor liver improve survival after liver transplantation in rats. Transplant Proc 1991; 23: 2465-2466.
25. Hassanain M, Schricker T, Metrakos P, Carvalho G, Vrochides D, Lattermann R,. Hepatic protection by perioperative metabolic support? Nutrition 2008; 24: 1217-1219.
26. Alibegovic A, Ljungqvist O,. Pretreatment with glucose infusion prevents fatal outcome after hemorrhage in food deprived rats. Circ Shock 1993; 39: 1-6.
27. Ljungqvist O, Nygren J, Soop M, Thorell A,. Metabolic perioperative management: novel concepts. Curr Opin Crit Care 2005; 11: 295-299.
28. Krinsley J,. Perioperative glucose control. Curr Opin Anaesthesiol 2006; 19: 111-116.
29. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al., Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367.
30. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, et al., Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-827.
31. Tang LJ, Tian FZ, Gao XM,. Hepatocellular glycogen in alleviation of liver ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int 2002; 1: 532-535.
32. Wiezer M, Meijer C, Wallast-Groenewoud H, Tool A, Prins H, Houdijk A, et al., Impaired leukocyte phagocytosis in patients undergoing hemihepatectomy for liver metastases. Liver Transpl Surg 1999; 5: 238-245.
33. van de Poll MC, Derikx JP, Buurman WA, Peters WH, Roelofs HM, Wigmore SJ, et al., Liver manipulation causes hepatocyte injury and precedes systemic inflammation in patients undergoing liver resection. World J Surg 2007; 31: 2033-2038.
34. Schwabe RF, Brenner DA,. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583-G589.
35. Jeschke MG, Klein D, Bolder U, Einspanier R,. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004; 145: 4084-4093.